Press releases

View Press releases from

1 April, 2020

Karo Pharma enters the Swiss market with direct presence by acquiring Hygis SA

Karo Pharma AB (Karo) has today acquired Hygis SA (Hygis), a Swiss distributing company with exclusive distribution rights to Karo’s brands MultiGyn and MultiMam. Hygis operations is limited to the distribution of these brands and by the acquisition Karo gains control over the direct sales of its brands. Karo expects to reach an annual net...

Read more
27 March, 2020

Karo Pharma postpones the Annual General Meeting to 25 May, 2020

The board of directors of Karo Pharma Aktiebolag (”Karo Pharma”) has resolved to postpone the Annual General Meeting to 25 May, 2020. The previously communicated date for the meeting was 29 April 2020. The delay is due to the increased concern of the spread of COVID-19 with the related safety of the participants. A notice...

Read more
2 March, 2020

Karo Pharma completes the acquisition of product portfolio from LEO Pharma

Karo Pharma Aktiebolag (“Karo Pharma”) today announces that the acquisition of the intimate care and dermatology product portfolio from LEO Pharma for 90 MEUR, which was signed and announced by Karo Pharma on 23 December 2019 and approved by relevant competition authorities on 20 February 2020, has been completed.

Read more
4 February, 2020

Termination of Karo agreement with Pfizer

Karo Pharma AB (“Karo”) has been informed by Pfizer Inc. (“Pfizer”) about its decision to terminate the Research Collaboration and License Agreement, which the two companies entered in December 2011. Following the wind-down of this agreement, there will be no active collaboration agreements between the two companies. This information follows Pfizer’s decision to terminate a...

Read more